Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep862 | Thyroid cancer | ECE2015

Anaplastic thyroid carcinoma: The failure of conventional therapy but the real promise of targeted therapy

Lennon Paul , Deady Sandra , Healy Marie-Louise , Kinsella John , Timon Conrad , O'Neill James Paul

Introduction: Anaplastic thyroid cancer is a devastating disease with median survival between 1.2 and 10 months. The disease accounts for as little as 0.9–1.6% of total thyroid cancer cases, but may account for up to half of all thyroid cancer mortality. The aim of our study is to evaluate the prognostic factors and outcomes of patients diagnosed with anaplastic thyroid cancer in Ireland and review emerging treatments for this disease.Methods and de...